|
Mangalam Drugs and Organics Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
63.47 Cr.
|
P/BV
|
0.50
|
Book Value (Rs.)
|
80.60
|
|
52 Week High/Low (Rs.)
|
116/23
|
FV/ML
|
10/1
|
P/E(X)
|
9.44
|
|
Bookclosure
|
25/09/2018
|
EPS (Rs.)
|
4.25
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR |
| FaceValue | 10.00 | 10.00 |
| | | |
| | | |
| INCOME | | |
| Revenue From Operations [Net] | 317.58 | 367.35 |
| Other Operating Revenues | 0.65 | 1.24 |
| Total Operating Revenues | 318.23 | 368.59 |
| | | |
| Other Income | 0.50 | 0.10 |
| Total Revenue | 318.73 | 368.69 |
| | | |
| EXPENSES | | |
| Cost Of Materials Consumed | 170.56 | 224.76 |
| Purchase Of Stock-In Trade | 18.33 | 10.65 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -21.52 | 9.10 |
| Employee Benefit Expenses | 40.59 | 39.07 |
| Finance Costs | 14.93 | 13.92 |
| Depreciation And Amortisation Expenses | 16.61 | 14.65 |
| Other Expenses | 74.45 | 67.61 |
| Total Expenses | 313.95 | 379.77 |
| | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 4.79 | -11.07 |
| | | |
| Profit/Loss Before Tax | 4.79 | -11.07 |
| | | |
| Tax Expenses-Continued Operations | | |
| Current Tax | 0.91 | 0.01 |
| Less: MAT Credit Entitlement | 0.83 | 0.00 |
| Deferred Tax | -2.02 | -2.20 |
| Tax For Earlier Years | 0.00 | 0.19 |
| Total Tax Expenses | -1.93 | -2.00 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 6.72 | -9.07 |
| | | |
| Profit/Loss From Continuing Operations | 6.72 | -9.07 |
| | | |
| Profit/Loss For The Period | 6.72 | -9.07 |
| Consolidated Profit/Loss After MI And Associates | 6.72 | -9.07 |
| | | |
| OTHER INFORMATION | | |
| | | |
| EARNINGS PER SHARE | | |
| Basic EPS (Rs.) | 4.25 | -5.73 |
| Diluted EPS (Rs.) | 4.25 | -5.73 |
